Single oral dose, crossover bioequivalence study with at least 7 days washout period between two consecutive periods, blood samples will be collected at time 0.00 to 72.00 hours post-dose in each peri
Sponsors
International Bio Service Co., Ltd.
Conditions
Healthy volunteer
Bilastine, Bioequivalence Study, Healthy Thai VolunteerHealthy volunteer
dapagliflozin, Bioequivalence Study, Healthy Thai Volunteer
Phase 1
Bioequivalence Study of Bilastine 20 mg Tablets in Healthy Thai Volunteers
TCTR20250129004
Start: 2025-03-12Target: 36Updated: 2026-08-03
Bioequivalence Study of Dapagliflozin 10 mg Film-coated Tablets in Healthy Thai Volunteers
Active, not recruitingTCTR20250606009
Start: 2025-07-29Target: 42Updated: 2026-08-03